Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

    2026-05-21

    Technical Application of (S)-(+)-Dimethindene maleate in M2 Muscarinic Receptor Research

    What This Product Solves

    (S)-(+)-Dimethindene maleate (SKU B6734) addresses the precise need for a selective M2 muscarinic receptor antagonist in research settings. Its defined affinity for the M2 muscarinic acetylcholine receptor, with reduced interaction at M1, M3, and M4 subtypes, allows researchers to dissect the specific role of M2 signaling in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. Additionally, its antagonism at the histamine H1 receptor provides a dual-modality tool for studying receptor interplay in complex tissues or systems. The product's high purity (98.00%), solid form, and water solubility streamline assay preparation, minimize ambiguity in pharmacological studies, and facilitate reproducibility in both in vitro and ex vivo experimental designs. For detailed product composition and preparation, refer to the (S)-(+)-Dimethindene maleate product page.

    Protocol Parameters

    • Assay: Solution Preparation | Value: Water-soluble at ≥20.45 mg/mL | Applicability: Enables rapid stock solution setup for cell-based and tissue assays | Rationale: Ensures accurate dosing and minimizes precipitation risk at typical working concentrations | Source: Product dossier
    • Assay: Storage Conditions | Value: Desiccated at room temperature (solid) | Applicability: Preserves compound stability and prevents hydrolysis or degradation during storage | Rationale: Solid-state storage minimizes moisture uptake; avoid long-term storage of aqueous solutions | Source: Product dossier
    • Assay: Solution Handling | Value: Use freshly prepared solutions; avoid long-term storage | Applicability: Maintains pharmacological activity and reproducibility across experiments | Rationale: Aqueous solutions may degrade or lose potency if held for extended periods | Source: Product dossier
    • Assay: Recommended Working Concentration | Value: User-defined, based on experimental design | Applicability: Dose selection should be guided by pilot studies and literature precedent for muscarinic acetylcholine receptor signaling pathway assays | Rationale: No universal working concentration; titration advised for each application | Source: Workflow recommendation

    Workflow Setup and QC Checklist

    • Confirm the physical state and batch purity prior to use (98.00% minimum as specified on APExBIO).
    • Weigh the required amount in a low-humidity environment to minimize water uptake, especially if working at or near the solubility limit.
    • Prepare stock solutions in sterile, deionized water at concentrations not exceeding 20.45 mg/mL to avoid precipitation; vortex thoroughly to ensure full dissolution.
    • Aliquot stocks immediately after preparation to reduce freeze-thaw cycles if short-term storage is unavoidable; however, best practice is to prepare fresh for each experiment.
    • Use freshly prepared solutions within the same working session. Discard unused solution to avoid variability in receptor antagonism due to potential degradation.
    • Include appropriate positive and negative controls in all receptor selectivity or functional assays to verify compound specificity and assay sensitivity.
    • Document all lot numbers, preparation dates, and storage conditions for traceability and reproducibility.

    For a scenario-based setup and troubleshooting focus, see the internal article (S)-(+)-Dimethindene maleate: Reliable M2 Antagonist for..., which details cell viability and proliferation workflows.

    Common Failure Modes and Fixes

    • Precipitation in Solution: If the compound does not fully dissolve at target concentrations, verify that the solubility threshold (≥20.45 mg/mL in water) is not exceeded. Use gentle heating (≤37°C) and vortexing, but avoid high temperatures that may induce decomposition.
    • Loss of Activity: Decreased antagonistic effect in cellular or tissue assays may result from aged or improperly stored solutions. Always use freshly prepared solutions and avoid storing reconstituted compound for extended periods.
    • Batch Variability: If assay outcomes vary across experiments, confirm product purity and lot details. Ensure all reagents and buffers are within their expiration and are handled under consistent conditions.
    • Non-specific Effects: If off-target effects are observed, verify that experimental concentrations are aligned with those recommended for selective muscarinic M2 receptor antagonist activity (as determined by pilot titration or literature precedent). Use control compounds to distinguish specific from non-specific signaling outcomes.

    For additional real-world troubleshooting strategies and workflow enhancements, refer to (S)-(+)-Dimethindene Maleate: Selective M2 Antagonist for..., which discusses comparative advantages and QC methods.

    Scope and Limitations

    • (S)-(+)-Dimethindene maleate is intended exclusively for scientific research use; it is not validated for diagnostic or therapeutic applications.
    • Its receptor selectivity profile is well-defined for M2 muscarinic and H1 histamine antagonism but has limited reported interaction with M1, M3, and M4 subtypes. Applications outside autonomic regulation, cardiovascular physiology, and respiratory system function require independent validation.
    • Quantitative potency, in vivo pharmacokinetics, and tissue distribution data are not provided in the product dossier; researchers must determine experimental suitability through pilot analysis. Avoid extrapolation to clinical or translational endpoints without supporting data.
    • Long-term storage of prepared solutions is not recommended; always prepare fresh to ensure consistency and activity.
    • Consult APExBIO technical documentation for any updates to handling, safety, or chemical compatibility before use.

    Conclusion

    (S)-(+)-Dimethindene maleate provides a robust, selective tool for dissecting muscarinic acetylcholine receptor signaling and histamine H1 pathways in autonomic, cardiovascular, and respiratory research. Its solubility, purity, and well-documented handling parameters make it suitable for reproducible, high-specificity studies when used according to recommended protocols. For full technical information and ordering, visit the (S)-(+)-Dimethindene maleate page. For comprehensive workflow guidance and troubleshooting in related assays, consult the provided internal articles. Always observe the defined limitations and avoid use outside validated research applications.